SCHEMBL826233

SCHEMBL826233

FC(F)C[N]C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18764 0.60
SCHEMBL27995013 0.60
Ammonia Solution, Strong SCHEMBL28412649 0.57
SCHEMBL8712085 0.57
Fluoride SCHEMBL6364058 0.57
SCHEMBL1998811 0.57
SCHEMBL1998724 0.57
SCHEMBL16215461 0.57
SCHEMBL679693 0.57
Fluoride Ion SCHEMBL6364056 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657024-B2 Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival STATEGICS, INC. (US) 2017-05-23 US disclosed
US-20150307498-A1 SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2015-10-29 US disclosed
US-9163027-B2 Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival STATEGICS, INC. (US) 2015-10-20 US disclosed
US-20140142122-A1 SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL STATEGICS, INC. (US) 2014-05-22 US disclosed
US-8143287-B2 Thrombopoietin mimetics STATEGICS, INC. (US) 2012-03-27 US disclosed
US-20100323965-A1 Thrombopoietin Mimetics STATEGICS, INC. (US) 2010-12-23 US disclosed
US-7786159-B2 Thrombopoietin mimetics STATEGICS, INC. (US) 2010-08-31 US disclosed
US-20080139621-A1 Thrombopoietin Mimetics STATEGICS, INC. (US) 2008-06-12 US disclosed